Evaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors

Of more than 150,000 published studies evaluating new biomarkers, fewer than 100 biomarkers have been implemented for patient care[1]. One reason for this is lack of rigorous testing by the medical community to validate claims for biomarker clinical relevance, and potential reluctance to publish neg...

Descripción completa

Detalles Bibliográficos
Autores principales: Lezcano, Cecilia, Lee, Chung-Wei, Larson, Allison R., Menzies, Alexander M., Kefford, Richard F., Thompson, John F., Mihm, Martin C., Ogino, Shuji, Long, Georgina V., Scolyer, Richard A., Murphy, George F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107197/
https://www.ncbi.nlm.nih.gov/pubmed/24434899
http://dx.doi.org/10.1038/modpathol.2013.226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107197/
https://www.ncbi.nlm.nih.gov/pubmed/24434899
http://dx.doi.org/10.1038/modpathol.2013.226

Ejemplares similares